Skip to main content
Journal cover image

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.

Publication ,  Journal Article
Hess, PL; Laird, A; Edwards, R; Bardy, GH; Bigger, JT; Buxton, AE; Moss, AJ; Lee, KL; Hall, WJ; Steinman, R; Dorian, P; Hallstrom, A ...
Published in: Heart Rhythm
June 2013

BACKGROUND: Whether there is an optimal time to place an implantable cardioverter-defibrillator (ICD) more than 40 days after myocardial infarction (MI) in guideline-eligible patients is unknown. OBJECTIVE: To evaluate the effect of time from MI to randomization on mortality, rehospitalizations, and complications. METHODS: Individual data on patients enrolled in 9 primary prevention ICD trials were provided. Clinical trials were eligible for the current analysis if they enrolled patients with an MI more than 40 days prior to randomization to primary prevention ICD therapy vs usual care: Multicenter Automatic Defibrillator Implantation Trial I, Multicenter UnSustained Tachyardia Trial, Multicenter Automatic Defibrillator Implantation Trial II, and Sudden Cardiac Death in Heart Failure Trial. RESULTS: ICD recipients died less frequently than nonrecipients at 5 years across all subgroups of time from MI to randomization. In unadjusted Cox proportional hazards regression, a survival benefit was evident in most subgroups. Adjusted Bayesian Weibull survival modeling yielded hazard ratio (HR) 0.50, 95% posterior credible interval (PCI) 0.20-1.25 41-180 days after MI; HR 0.98, 95% PCI 0.37-2.37 181-365 days after MI; HR 0.22, 95% PCI 0.07-0.59>1-2 years after MI; HR 0.42, 95% PCI 0.17-0.90>2-5 years after MI; HR 0.55, 95% PCI 0.25-1.15>5-10 years after MI; and HR 0.48, 95% PCI 0.20-1.02>10 years after MI. There was no evidence of an interaction between time from MI and all-cause mortality, rehospitalizations, or complications. CONCLUSIONS: In this meta-analysis, there was scant evidence that the efficacy of primary prevention ICD therapy depends on time to implantation more than 40 days after MI. Similarly, there was no evidence that the risks of rehospitalizations or complications depend on time more than 40 days after MI.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

June 2013

Volume

10

Issue

6

Start / End Page

828 / 835

Location

United States

Related Subject Headings

  • Time Factors
  • Randomized Controlled Trials as Topic
  • Proportional Hazards Models
  • Primary Prevention
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Hospitalization
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hess, P. L., Laird, A., Edwards, R., Bardy, G. H., Bigger, J. T., Buxton, A. E., … Sanders, G. D. (2013). Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm, 10(6), 828–835. https://doi.org/10.1016/j.hrthm.2013.02.011
Hess, Paul L., Amy Laird, Rex Edwards, Gust H. Bardy, J Thomas Bigger, Alfred E. Buxton, Arthur J. Moss, et al. “Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.Heart Rhythm 10, no. 6 (June 2013): 828–35. https://doi.org/10.1016/j.hrthm.2013.02.011.
Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LYT, Sanders GD. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm. 2013 Jun;10(6):828–835.
Journal cover image

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

June 2013

Volume

10

Issue

6

Start / End Page

828 / 835

Location

United States

Related Subject Headings

  • Time Factors
  • Randomized Controlled Trials as Topic
  • Proportional Hazards Models
  • Primary Prevention
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Hospitalization
  • Female